CA3168571A1 - Production de proteine recombinante soluble - Google Patents

Production de proteine recombinante soluble Download PDF

Info

Publication number
CA3168571A1
CA3168571A1 CA3168571A CA3168571A CA3168571A1 CA 3168571 A1 CA3168571 A1 CA 3168571A1 CA 3168571 A CA3168571 A CA 3168571A CA 3168571 A CA3168571 A CA 3168571A CA 3168571 A1 CA3168571 A1 CA 3168571A1
Authority
CA
Canada
Prior art keywords
gene
protein
recombinant cell
peptide
methionine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3168571A
Other languages
English (en)
Inventor
Min-ju CHANG
Natalia OGANESYAN
Andrew Lees
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fina BioSolutions LLC
Original Assignee
Fina BioSolutions LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/819,775 external-priority patent/US11060123B2/en
Application filed by Fina BioSolutions LLC filed Critical Fina BioSolutions LLC
Publication of CA3168571A1 publication Critical patent/CA3168571A1/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0051—Oxidoreductases (1.) acting on a sulfur group of donors (1.8)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/485—Exopeptidases (3.4.11-3.4.19)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y108/00—Oxidoreductases acting on sulfur groups as donors (1.8)
    • C12Y108/01—Oxidoreductases acting on sulfur groups as donors (1.8) with NAD+ or NADP+ as acceptor (1.8.1)
    • C12Y108/01007—Glutathione-disulfide reductase (1.8.1.7), i.e. glutathione reductase (NADPH)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y108/00—Oxidoreductases acting on sulfur groups as donors (1.8)
    • C12Y108/01—Oxidoreductases acting on sulfur groups as donors (1.8) with NAD+ or NADP+ as acceptor (1.8.1)
    • C12Y108/01008—Protein-disulfide reductase (1.8.1.8), i.e. thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/11—Aminopeptidases (3.4.11)
    • C12Y304/11018—Methionyl aminopeptidase (3.4.11.18)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention concerne des procédés et des compositions pour l'expression et la purification de produits tels que des peptides et des protéines dans des micro-organismes. En particulier, des pré-produits sont exprimés par recombinaison, le cytoplasme du micro-organisme modifiant les pré-produits exprimés pour produire des produits sous une forme active/finale ou autrement souhaitable. Des modifications associées à l'expression d'un produit recombinant souhaité comprennent le décalage de l'état redox du cytoplasme pour permettre un repliement correct des protéines, le clivage site-dirigé de pré-protéines pour activer la protéine, le clivage site-dirigé d'une méthionine indésirable à partir de l'extrémité N de la protéine, et/ou une ou plusieurs ligations pour former des configurations souhaitées des protéines, le tout dans la même cellule.
CA3168571A 2020-03-16 2021-03-12 Production de proteine recombinante soluble Pending CA3168571A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202062990083P 2020-03-16 2020-03-16
US62/990,083 2020-03-16
US16/819,775 US11060123B2 (en) 2014-01-31 2020-03-16 Production of soluble recombinant protein without n-terminal methionine
US16/819,775 2020-03-16
US202163152954P 2021-02-24 2021-02-24
US63/152,954 2021-02-24
PCT/US2021/022126 WO2021188379A2 (fr) 2020-03-16 2021-03-12 Production de protéine recombinante soluble

Publications (1)

Publication Number Publication Date
CA3168571A1 true CA3168571A1 (fr) 2021-09-23

Family

ID=77772149

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3168571A Pending CA3168571A1 (fr) 2020-03-16 2021-03-12 Production de proteine recombinante soluble

Country Status (7)

Country Link
EP (1) EP4121541A2 (fr)
JP (1) JP7449000B2 (fr)
KR (1) KR20220154221A (fr)
CN (1) CN115867661A (fr)
AU (1) AU2021239914A1 (fr)
CA (1) CA3168571A1 (fr)
WO (1) WO2021188379A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117603323A (zh) * 2023-05-16 2024-02-27 张文康 一种肉毒毒素的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071718A (en) 1996-11-27 2000-06-06 Abbott Laboratories Methods of producing a recombinant protein
JP4870574B2 (ja) 2003-12-19 2012-02-08 ノヴォ ノルディスク アー／エス ペプチドおよびタンパク質のプロセシング
US20060286629A1 (en) * 2003-12-19 2006-12-21 Norby Inga S N Processing of Peptides and Proteins
TW201343911A (zh) 2012-04-18 2013-11-01 Providence University 生產成熟型人類酪胺酸酶的大腸桿菌表現系統及其生產方法
KR102282930B1 (ko) * 2014-01-31 2021-07-27 피나 바이오솔루션스, 엘엘씨 Crm197 및 관련 단백질의 발현 및 정제

Also Published As

Publication number Publication date
KR20220154221A (ko) 2022-11-21
WO2021188379A3 (fr) 2021-10-28
JP7449000B2 (ja) 2024-03-13
EP4121541A2 (fr) 2023-01-25
AU2021239914A1 (en) 2022-09-08
CN115867661A (zh) 2023-03-28
WO2021188379A2 (fr) 2021-09-23
JP2023517708A (ja) 2023-04-26

Similar Documents

Publication Publication Date Title
US10287330B2 (en) Methods and compositions relating to CRM197
EP1206554B2 (fr) Neurotoxines de recombinaison activables
US5427927A (en) Process for the enzymatic cleavage of recombinant proteins using IgA proteases
EP2280066A2 (fr) Fragments recombinants de la neurotoxine de Clostridium
HU205386B (en) Process for expressing cloned lysostaphin gene and for producing dna fragment containing the gene, expression vector and transformed host cell
JP7449000B2 (ja) 可溶性の組換えタンパク質の生成
RU2144957C1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pPINS07, КОДИРУЮЩАЯ ГИБРИДНЫЙ ПОЛИПЕПТИД, СОДЕРЖАЩИЙ ПРОИНСУЛИН ЧЕЛОВЕКА, И ШТАММ БАКТЕРИЙ Escherichia coli - ПРОДУЦЕНТ ГИБРИДНОГО ПОЛИПЕПТИДА, СОДЕРЖАЩЕГО ПРОИНСУЛИН ЧЕЛОВЕКА
US20230242961A1 (en) Production of Soluble Recombinant Protein
US11060123B2 (en) Production of soluble recombinant protein without n-terminal methionine
KR102142255B1 (ko) Crm197 단백질 발현 방법
RU2143492C1 (ru) Рекомбинантная плазмида, кодирующая гибридный белок - предшественник инсулина человека (варианты), штамм бактерий e.coli - продуцент гибридного белка - предшественника инсулина человека (варианты), способ получения инсулина человека
IL100623A (en) PROCESS FOR THE PRODUCTION OF RECOMBINANT IgA PROTEASE AND THE IgA PROTEASE PRODUCED THEREBY
RU2144082C1 (ru) Рекомбинантная плазмида, кодирующая гибридный белок-предшественник инсулина человека (варианты), штамм бактерий e.coli - продуцент гибридного белка-предшественника инсулина человека (варианты) и способ получения инсулина человека
KR102643064B1 (ko) 발현 수준 및 가용성이 증대된 인간 엔테로키나제 융합 단백질 및 그 제조방법
RU2120475C1 (ru) Способ получения представляющего интерес полипептида, гибридная днк (варианты), слитый белок (варианты)
RU2347811C1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pET-KSI-Buf2, КОДИРУЮЩАЯ ГИБРИДНЫЙ БЕЛОК, СОДЕРЖАЩИЙ АНТИМИКРОБНЫЙ ПЕПТИД БУФОРИН-2, ШТАММ Escherichia coli BL21(DE3)/pET-KSI-Buf2 - ПРОДУЦЕНТ УКАЗАННОГО БЕЛКА И СПОСОБ ПОЛУЧЕНИЯ АНТИМИКРОБНОГО ПЕПТИДА БУФОРИНА-2
JP3489865B2 (ja) ヒト成長ホルモンの製造法
US20210348174A1 (en) Production of Soluble Recombinant Proteins without N-Terminal Methionine in E-Coli
WO2021045292A1 (fr) Procédé d'expression de protéine crm197
RU2077585C1 (ru) Рекомбинантная плазмидная днк рдти 23, способ получения рекомбинантной плазмидной днк рдти 23 и штамм бактерий escherichia coli, содержащий рекомбинантную плазмидную днк рдти 23 - продуцент слитого белка дтил 2
JP2006320220A (ja) プロテインａ融合ポリペプチドの製造に利用するｄｎａ配列、組換え発現ベクター、形質転換体、およびその融合ポリペプチドの製造方法
CN115927263A (zh) 一种IgA蛋白酶及其制备方法
KR20040031664A (ko) 클로로히드린 및 하이드록시카르복실산 에스테르 부제가수분해 효소 유전자
JPH03277278A (ja) シュードモナス・アエルギノーザ由来アルカリプロテアーゼ遺伝子
JP2003038195A (ja) 融合蛋白質より有用蛋白質を取得する方法

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220818

EEER Examination request

Effective date: 20220818

EEER Examination request

Effective date: 20220818

EEER Examination request

Effective date: 20220818

EEER Examination request

Effective date: 20220818

EEER Examination request

Effective date: 20220818

EEER Examination request

Effective date: 20220818

EEER Examination request

Effective date: 20220818